| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | China | 1 | |
| #4 | France | 1 | |
| #5 | Hong Kong | 1 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Foods and drinks | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Foods | |
| #4 | Special foods | |
| #5 | Specific use of cosmetics |
| # | Name | Total Patents |
|---|---|---|
| #1 | Souchet Michel | 12 |
| #2 | Karaboga Arnaud Sinan | 12 |
| #3 | Gegout Stéphane | 4 |
| #4 | Gegout Stephane | 3 |
| #5 | Pillot Thierry | 2 |
| Publication | Filing date | Title |
|---|---|---|
| FR3067249A1 | Cosmetic compositions comprising natural extracts and uses thereof | |
| EP3426273A1 | Sublingual compositions comprising natural extracts and uses thereof | |
| WO2014083171A1 | Natural compounds for use in the treatment of beta-2 adrenergic receptor related diseases | |
| EP2626073A1 | Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (PDE4) |